Abstract
Objectives: To explore awareness of human papillomavirus (HPV) and use of HPV vaccines (Gardasil and Cervarix) by college students. Participants: The sample was composed of 817 undergraduates at 2 northeastern US universities; they participated between February and May 2010. Methods: Students were provided with a link to an anonymous, self-administered, Web-based survey comprised of 76 questions. The survey included questions about health behaviors, awareness, and knowledge of HPV and the 2 HPV vaccines, and vaccine uptake. Results: Results indicate high levels of awareness of HPV as well as marked sex differences related to vaccine awareness and uptake. Both sexes are largely unaware of Cervarix and the differences between Cervarix and Gardasil. Conclusion: The study affirms the importance of a clinician's recommendation for HPV vaccination. Public health messaging should become more inclusive of adolescent and young adult males. College students’ awareness of HPV vaccine options mirrors Gardasil's market dominance in the United States.
Keywords:
FUNDING
No funding was used to support this research and/or the preparation of the manuscript.
CONFLICT OF INTEREST DISCLOSURE
Dr Mahoney has previously served on the speakers bureaus for both Merck and GlaxoSmithKline related to the topic of HPV vaccination. The other authors have no conflicts of interest to report.
The authors confirm that the research presented in this article met the ethical guidelines, including adherence to the legal requirements, of the United States and received approval from the Roswell Park Cancer Institute Institutional Review Board.
NOTE
For comments and further information, address correspondence to Sarah Beshers, PhD, Health Department, State University of New York at Cortland, PO Box 2000, Cortland, NY 13045, USA (e-mail: [email protected]).